Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Aug 5 |
| JAZZ |
| Jazz Pharmaceuticals plc |
| AGRANT |
| 1,605 |
| — |
| — |
| +105.1% |
| Open the original filing on SEC.gov |
| Jun 17 | GPCR | Structure Therapeutics… | AGRANT◆ | 39,453 | — | — | — | Open the original filing on SEC.gov |
| Jun 5 | RPRX | Royalty Pharma plc | AGRANT | 4,545 | — | — | +8.4% | Open the original filing on SEC.gov |
| Apr 30 | GILD | Gilead Sciences, INC. | AGRANT◆ | 4,884 | — | — | — | Open the original filing on SEC.gov |
| Apr 30 | GILD | Gilead Sciences, INC. | AGRANT | 1,146 | — | — | +26.4% | Open the original filing on SEC.gov |
| Feb 26 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 1,527 | — | — | — | Open the original filing on SEC.gov |
| Jun 23, 2025 | GPCR | Structure Therapeutics… | AGRANT◆ | 51,804 | — | — | — | Open the original filing on SEC.gov |
| May 13, 2025 | RPRX | Royalty Pharma plc | AGRANT | 7,614 | — | — | +16.5% | Open the original filing on SEC.gov |
| May 7, 2025 | GILD | Gilead Sciences, INC. | AGRANT◆ | 6,809 | — | — | — | Open the original filing on SEC.gov |
| May 7, 2025 | GILD | Gilead Sciences, INC. | AGRANT | 1,516 | — | — | +53.7% | Open the original filing on SEC.gov |